YTTRIUM Y-90 CLIVATUZUMAB TETRAXETAN

UNII:	2L271110ED
Formula:
Preferred Substance Name:	YTTRIUM Y-90 CLIVATUZUMAB TETRAXETAN

943976-23-6
90HY-PAM4
90Y-HPAM4
90Y-HPAMA4
CONJ:MAB HUMANIZED (IGG1) ANTI P15941 (MUC1_HUMAN); YTTRIUM Y 90 (IMMU107)
HPAM4-DOTA
HPAM-4-DOTA
IMMU-107
IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER, 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID CONJUGATE, YTTRIUM-SUP(90)Y CHELATE
IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER, 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID CONJUGATE, YTTRIUM-SUP(90)Y CHELATE
PAN-CIDE
S9S0HY-PAM4
Y-90 HPAM4
YTTRIUM (90Y) CLIVATUZUMAB TETRAXETAN
YTTRIUM (90Y) CLIVATUZUMAB TETRAXETAN [INN]
YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN
YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

YTTRIUM Y-90 CLIVATUZUMAB TETRAXETAN

Synonyms and Mappings

Resources